- Patent
- Trademark
- Innovation
- Legal Operations
- Localization
- Contact
- Learn & Support
- Learn and support
- Resource HubAccess value added content to support your IP strategy
- Webinars & EventsAre you interested in attending one of our online or onsite event?
- Product TrainingsCustomer success is our priority. Increase your skills in the use of Questel’s software
- Product NewsA platform dedicated to software and platforms news and evolutions
- eLearning ProgramsCreate engaging and custom corporate training programs
- Resource Hub
- About Questel
- Learn & Support
- Learn and support
- Resource HubAccess value added content to support your IP strategy
- Webinars & EventsAre you interested in attending one of our online or onsite event?
- Product TrainingsCustomer success is our priority. Increase your skills in the use of Questel’s software
- Product NewsA platform dedicated to software and platforms news and evolutions
- eLearning ProgramsCreate engaging and custom corporate training programs
- Resource Hub
- About Questel
Technology Landscape Metrics
The graph shows the variation in percentage of the number of first patent filings related to the topic on a defined interval of years, by default on the 3 last years.
A new invention represents the first-filing of a technology and is based on the first application date of the family.
The technology growth trend assessment is based on the following values:
Variation in % | Growth Trend |
---|---|
>50% | Booming |
Between 20 and 50% | Trending |
Between 10 and 20% | Quite trending |
Between 0 and 10% | Steady |
< 0% | Decline |
The Protected patent graph shows the volumes of protected patents by country over the last 10 years: it is based on the number of patent families on the topic by country (top 10) over the last 10 years
The First fillings graph shows the volumes of first filings related to the topic by country over the last 10 years: it is based on the number of first patent filings on the topic by country (top 10).
The Best Accelerations graph shows the countries with the strongest acceleration in terms of volume of protected patents over the last year in the top 30 countries. The acceleration is calculated between the last 2 complete years.
The method of calculation is based on the originality index, measuring the dispersion of citing patents over technology classes. The Originality index is defined as the average of the originality index calculated for each patent family (value between 0 and 1). The greater the dispersion of IPC / CPC subclasses of the cited patents, the higher the index. Complete definition by Hall Jaffe and Trajtenberg (2001)
The Patent filing strategy qualification is defined as following :
- < 0.80 Incremental
- >= 0.80 Disruptive
Incremental innovation is a series of small improvements to an existing product or product line that usually helps maintain or improve its competitive position over time. Incremental innovation is regularly used within the high technology business by companies that need to continue to improve their products to include new features increasingly desired by consumers.
According to Clayton Christensen in “The Innovator’s Dilemma,” (1997), disruptive innovation is is an innovation that creates a new market and value network and eventually disrupts an existing market and value network, displacing established market-leading firms, products, and alliances.
The Innovation Cycle qualification is based on the following values:
Percentage of patent families on the topic held by the top 10 actors | Innovation Cycle is considered as : |
---|---|
>50% | Ending |
from 30 to 50% | Slowing |
from 20 to 30% | Ongoing |
from 10 to 20% | Beginning |
from 1 to 10% | Emerging |
The graph shows the top 5 of actors ordered by patents number on the topic and the percentage of the cumulated number of the top 5 players compared to the top 100.
The graph shows the top 5 of actors ordered by patents number on the topic and the percentage of the cumulated number of the top 5 players compared to the top 100.
The list of starts up includes starts ups and SMEs that have published scientific document(s) or filed patent(s) or participated to project(s) or clinical trial(s) or communicated on topics related to your search.
Start-ups are defined by the number of employees below 250.
Starts ups are ordered by default by relevance. The relevancy of a start up is mainly based on the following indicators:
- Number of published documents (all types of documents)
- Sum of the scores of its documents (all types)
- Centrality in the query network : the centrality is an indicator based on the number and distance of connections of a node in a network.
- Diversity of scientific works (number of different types)
- Sum of the scores of the start up web pages
The graph shows the Top 3 of the most relevant experts on the topic.
The relevancy of an expert is mainly based on the following indicators :
- Number of published documents (all types of documents)
- Sum of the scores of his documents (all types)
- Centrality in the query network : the centrality is an indicator based on the number and distance of connections of a node in a network.
- Diversity of scientific works (number of different types)
The relevancy of a document is mainly based on the following indicators :
- Number of occurrences of the searched concept
- Position of the concept within the document (Title, Abstract, Keywords)
- Publication date of the document : most recent documents are privileged
- Type of document (A scientific poster will have less weight than a a peer reviewed article)
The graph shows Top 3 of the most relevants academics on the topic.
The relevancy of an academic is mainly based on the following indicators :
- Number of published documents (all types of documents)
- Sum of the scores of its documents (all types)
- Centrality in the query network : the centrality is an indicator based on the number and distance of connections of a node in a network.
- Diversity of scientific works (number of different types)
- Sum of the scores of the academic web pages
The relevancy of a document is mainly based on the following indicators :
- Number of occurrences of the searched concept
- Position of the concept within the document (Title, Abstract, Keywords)
- Publication date of the document : most recent documents are privileged
- Type of document (A scientific poster will have less weight than a a peer reviewed article)
The qualification of the collaborative network on a topic is based on the following values:
Collaboration Type on the topic | Collaboration network is |
---|---|
If industrial collaboration is >=65% | mainly industrial |
If academic collaboration is >=65% | mainly academic |
For all others distributions | both industrial & academic |
Collaboration level on the topic | Collaboration level is |
---|---|
>65% | High |
<65% | Moderate |
<15% | Low |
Collaboration Scope on the topic | Collaboration network is |
---|---|
>50% international collaborations | Mainly worlwide |
The IP investment (sum of the costs of patents families on the topic) is calculated by an algorithm. This algorithm estimates the cost of each procedure on 2018, 2019 and 2020 according to the patents still alive in each family (taxes, cabinet cost, number of actions…).
The IP Market size is based on the following values :
IP Market size | Sum of the costs of patents families on the topic |
---|---|
Small | < 10 M$ |
Medium | Between 10 et 100 M$ |
Big | >100 M$ |
The graph shows the percentage variance in relation with the following known markets :
IP Market size | Known Markets |
---|---|
Small | Artificial Intelligence in BlockChain |
Small | Graphene Battery |
Medium | Crispr |
Medium | Driverless |
Big | Artificial Intelligence |
Big | Oncology |
Big | Cellular network |
The graph shows the trend of institutional investments on the topic : each column indicates the sum of the institutional funds of the European and US financed projects (FP5, FP6, FP7, H2020, SBIR, STTR) related to the topic per year.
The funding qualification is based on the following values:
Funding | Funding is considered |
---|---|
0 | Not funded right now |
<1M$ | Lowly funded |
<50M$ | Moderatly funded |
>50M$ | Highly funded |
The graph shows the trend of clinical investments on the topic by years.
Investments are calculating aggregating clinical trials costs and using estimated costs by phase as follow :
Phases | Estimated costs |
---|---|
Phase 1 | 4 M$ |
Phase 2 | 13 M$ |
Phase 3 | 20 M$ |
FDA NDA / BLA | 2 M$ |
Phase 4 | 20 M$ |
More info : https://aspe.hhs.gov/report/examination-clinical-trial-costs-and-barriers-drug-development
The funding qualification is based on the following values:
Funding | Funding is considered |
---|---|
0 | Not funded right now |
<1M$ | Lowly funded |
<50M$ | Moderatly funded |
>50M$ | Highly funded |
The Market Strategy Index of each patent family corresponds to the size of the market in the countries (using the corresponding GDP) covered by the family.
To calculate this metric, several factors are considered:
- alive patent applications + any granted patent (either dead or alive)
- A 40% reduction is applied to pending countries.
- WO/pending EPs market size is calculated based on the statistical chance of patents to be finally designated in the different authorities.
Data is normalized in order to give a score of 1 to an invention which only cover US with a granted patent.
The qualification of the Market Strategy is based on the following values :
Market Strategy Index | Strategy |
---|---|
<0,6 | Local |
>0,6 and <0,9 | Main Markets |
>0,9 | Global |
The graph shows the most common concepts found in the full text of the patents and allows to identify the most mainstream technologies.
The graph in the form of a pie chart shows the Top 3 Technology domains (TECT fields) for the analyzed topic.
The graph shows the most common concepts found in the NPL meta-data and allows to identify the most mainstream scientific researches.
The graph in the form of a pie chart shows the Top 3 scientific domains for the analyzed topic andr extract from NPL.
Full list of scientific domains available here.